| |
Total (N = 103)
|
With SA (N = 75)
|
Without SA (N = 28)
|
p value
|
|---|
|
Hypertension (%)
|
55.3
|
56.0
|
53.6
|
1.00
|
|
Ischaemic aetiology (%)
|
54.4
|
54.7
|
53.6
|
1.00
|
|
Atrial fibrillation (%)
|
34.3
|
36.5
|
28.6
|
0.60
|
|
NYHA II-III vs I (%)
|
61.8
|
67.6
|
46.4
|
0.08
|
|
Echocardiography
| | | | |
|
Severe LVSD (%)
|
56.3
|
63.9
|
33.3
|
0.018
|
|
LVH (%)
|
12.1
|
16.2
|
0.0
|
0.03
|
|
LVEDD (mm)
|
59.0 (54.0-64.3)
|
60.0 (54.0-65.0)
|
56.0 (52.0-59.0)
|
0.01
|
|
LA (mm)
|
47.0 (41.0-51.0)
|
49.0 (44.0-52.0)
|
42.0 (38.0-48.0)
|
< 0.001
|
|
PSAP (mmHg)
|
48.0 (40.0-52.8)
|
50 (40-53)
|
45 (38-52)
|
0.46
|
|
NT-proBNP (pg/mL)
|
1260.6 (552.3-2493.2)
|
1317.6 (705.9-2218.9)
|
1137.7 (232.9-2718.2)
|
0.51
|
- AHI- apnoea-hypopnoea index; NYHA- New York Heart Association; LVSD- left ventricle systolic dysfunction; LVH- left ventricle hypertrophy; LVEDD- left ventricle end-diastolic diameter; LA- left atria; PSAP- pulmonary systolic arterial pressure; RV- right ventricle.
- Continuous data are expressed as median and interquartile range.
